Putting a New Spin on RNA, Remix Launches with $81 Million

Putting a New Spin on RNA, Remix Launches with $81 Million

Source: 
BioSpace
snippet: 

Remix Therapeutics announced today that it is officially launching with $81 million in financing. The funds will be used to support the development of the company’s REMaster technology platform. In addition, Remix will now be able to advance its pipeline of RNA processing targeted therapeutics as well.